Fig. 1From: “High-throughput screening of catalytically active inclusion bodies using laboratory automation and Bayesian optimization”Semi-automated CatIB construction workflow. Plasmids were commercially synthesized by Synbio Technologies (Monmouth Junction, US). Manual (light blue boxes), accelerated (dark blue framed boxes) and automated (dark blue boxes) cloning steps were performed to construct E. coli BL21(DE3) strains containing different episomally encoded CatIB variantsBack to article page